Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer

A major challenge in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast cancer. Here we provide the first preclinical evidence that a second-generation selenium compound, methylseleninic acid, significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yanfeng, Fu, Xueqi, Xiong, Zhenggang, Zhang, Haitao, Hill, Steven M., Rowan, Brian G., Dong, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279411/
https://www.ncbi.nlm.nih.gov/pubmed/22348099
http://dx.doi.org/10.1371/journal.pone.0031539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279411/
https://www.ncbi.nlm.nih.gov/pubmed/22348099
http://dx.doi.org/10.1371/journal.pone.0031539

Ejemplares similares